Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum.
Lapierre TJWJD, Farago DN, de Moura Lodi Cruz MGF, de Melo Resende D, de Oliveira ACR, Dos Santos BRM, de Oliveira Souza F, Michelan-Duarte S, Chelucci RC, Andricopulo AD, Ferreira LLG, Pilau EJ, Murta SMF, de Oliveira Rezende Júnior C. Lapierre TJWJD, et al. Among authors: andricopulo ad. Chem Biol Drug Des. 2024 Apr;103(4):e14525. doi: 10.1111/cbdd.14525. Chem Biol Drug Des. 2024. PMID: 38627214
Editorial: Drug Discovery for Neglected Diseases.
Andricopulo AD, Ferreira LLG. Andricopulo AD, et al. Curr Top Med Chem. 2018;18(5):313-314. doi: 10.2174/156802661805180611112621. Curr Top Med Chem. 2018. PMID: 29968533 No abstract available.
Chemoinformatics Strategies for Leishmaniasis Drug Discovery.
Ferreira LLG, Andricopulo AD. Ferreira LLG, et al. Among authors: andricopulo ad. Front Pharmacol. 2018 Nov 1;9:1278. doi: 10.3389/fphar.2018.01278. eCollection 2018. Front Pharmacol. 2018. PMID: 30443215 Free PMC article. Review.
Discovery of Potent, Reversible, and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-Based Drug Design Approach.
de Souza ML, de Oliveira Rezende Junior C, Ferreira RS, Espinoza Chávez RM, Ferreira LLG, Slafer BW, Magalhães LG, Krogh R, Oliva G, Cruz FC, Dias LC, Andricopulo AD. de Souza ML, et al. Among authors: andricopulo ad. J Chem Inf Model. 2020 Feb 24;60(2):1028-1041. doi: 10.1021/acs.jcim.9b00802. Epub 2019 Dec 11. J Chem Inf Model. 2020. PMID: 31765144
2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling.
Ferreira RAA, Junior COR, Martinez PDG, Koovits PJ, Soares BM, Ferreira LLG, Michelan-Duarte S, Chelucci RC, Andricopulo AD, Galuppo MK, Uliana SRB, Matheeussen A, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. Ferreira RAA, et al. Among authors: andricopulo ad. PLoS Negl Trop Dis. 2021 Feb 22;15(2):e0009196. doi: 10.1371/journal.pntd.0009196. eCollection 2021 Feb. PLoS Negl Trop Dis. 2021. PMID: 33617566 Free PMC article.
Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease.
de Oliveira Rezende Júnior C, Martinez PDG, Ferreira RAA, Koovits PJ, Miranda Soares B, Ferreira LLG, Michelan-Duarte S, Chelucci RC, Andricopulo AD, Matheeussen A, Van Pelt N, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. de Oliveira Rezende Júnior C, et al. Among authors: andricopulo ad. Eur J Med Chem. 2023 Jan 15;246:114925. doi: 10.1016/j.ejmech.2022.114925. Epub 2022 Nov 15. Eur J Med Chem. 2023. PMID: 36459758 Free article.
Drugs and vaccines in the 21st century for neglected diseases.
Ferreira LLG, Andricopulo AD. Ferreira LLG, et al. Among authors: andricopulo ad. Lancet Infect Dis. 2019 Feb;19(2):125-127. doi: 10.1016/S1473-3099(19)30005-2. Epub 2019 Jan 30. Lancet Infect Dis. 2019. PMID: 30712832 No abstract available.
160 results